Results 81 to 90 of about 64,974 (298)

Severe hypoglycemia in a patient with anorexia nervosa

Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2008
Severe hypoglycemia is an important but uncommon complication of anorexia nervosa. A 35-year-old woman showed severe hypoglycemia after a recovery from severe liver dysfunction due to malnutrition.To reveal the cause of severe hypoglycemia, we measured plasma hormones and performed a 75g oral glucose loading test.Fasting serum adrenocorticotropic ...
H, Yanai, H, Yoshida, Y, Tomono, N, Tada
openaire   +2 more sources

Therapeutic Applications of Stimuli‐Based Release and Engineering of Extracellular Vesicles

Advanced NanoBiomed Research, EarlyView.
This review summarizes the effects of endogenous and exogenous stimuli, their effects on the natural release of extracellular vesicles, as well as their uptake and release. It also gives an overview of stimuli‐responsive EVs and their therapeutic applications. Extracellular vesicles (EVs), nano‐ to microsized lipid bilayer membrane‐bound particles, are
Gloria Kemunto, Kristen Dellinger
wiley   +1 more source

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial

Arthritis &Rheumatology, EarlyView.
Objective Overweight or obesity is prevalent in 72% to 82% of individuals with psoriatic arthritis (PsA). We assessed the efficacy and safety of ixekizumab (IXE) concomitantly administered with tirzepatide (TZP) compared with IXE alone in adult participants with active PsA and overweight with at least one weight‐related comorbidity or obesity.
Joseph F. Merola, Philip Mease, Alan Kivitz, Naveed Sattar, Laura C. Coates, Daniel Aletaha, Cynthia E. Kartman, Peter Fischer, Luna Sun, Píndaro Martínez‐Osuna, Andris Kronbergs, Purvi Prajapati, Anabela Cardoso, Mark C. Genovese, Alexis Ogdie   +14 more
wiley   +1 more source

Multidisciplinary strategies to treat severe hypoglycemia in hospitalized patients with diabetes mellitus reduce inpatient mortality rate: Experience from an academic community hospital.

PLoS ONE, 2019
ObjectiveSevere hypoglycemia (blood glucose < 50 mg/dl) in hospitalized patients with diabetes mellitus is associated with poor outcomes such as increased mortality and readmission rates.
Deepak Kana Kadayakkara, Priyadarshini Balasubramanian, Katherine Araque, Karri Davis, Fahad Javed, Pontea Niaki, Sachin Majumdar, Gregory Buller   +7 more
doaj   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012.

PLoS Medicine, 2014
BackgroundSevere hypoglycemia is a major complication of insulin treatment in patients with type 1 diabetes, limiting full realization of glycemic control.
Beate Karges, Joachim Rosenbauer, Thomas Kapellen, Verena M Wagner, Edith Schober, Wolfram Karges, Reinhard W Holl   +6 more
doaj   +1 more source

Moxifloxacin: A Unique Cause of Severe Hypoglycemia

, 2016
As a class, quinolone antibiotics have been rarely associated with hypoglycemia in non-diabetic patients and rare reversible episodes of hypoglycemia documented in the literature typically occur within the duration of action of the medication.
Raschke, Jeremy, Khashaei, Sepehr, Ball, Emily   +2 more
core  

Meta-analysis of outcomes assessed in this overview: A: glycated hemoglobin—A1C; B: general hypoglycemia; C: severe hypoglycemia; D: nocturnal hypoglycemia.

, 2018
Meta-analysis of outcomes assessed in this overview: A: glycated hemoglobin—A1C; B: general hypoglycemia; C: severe hypoglycemia; D: nocturnal hypoglycemia.
Everton N. Silva (5094653), Ana C. M. G. Figueiredo (5094656), Keitty R. C. de Andrade (5094650), Fernanda O. Laranjeira (5094659), Mauricio G. Pereira (380987)   +4 more
core   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Severe Hypoglycemia Predicts Mortality in Diabetes [PDF]

Diabetes Care, 2012
In this issue of Diabetes Care , McCoy et al. (1) report 3.4-fold higher mortality in patients with diabetes who self-reported severe hypoglycemia (that which required the assistance of another person) 5 years earlier. They suggest that patient-related outcomes such as hypoglycemia would augment risk stratification and management of patients with ...
openaire   +2 more sources